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— Ultrasonography (US) is also one of the procedures that
should be performed in all patients with suspected acute
pancreatitis.
— Magnetic resonance imaging (MRI) is one of the most
important imaging procedures for diagnosing acute pan-
creatitis and its intraperitoneal complications.
— Computed tomography (CT) is also one of the most im-
portant imaging procedures for diagnosing acute pancre-
atitis and its intraabdominal complications. CT should be
performed when a diagnosis of acute pancreatitis cannot
be established on the basis of the clinical ﬁndings, results
of blood and urine tests, or US, or when the etiology of the
pancreatitis is unknown.
— When acute pancreatitis is suspected, chest and abdominal
X-ray examinations should be performed to determine
whether any abnormal ﬁndings caused by acute pancreati-
tis are present.
— Because the etiology of acute pancreatitis can have a cru-
cial inﬂuence on both the treatment policy and severity
assessment, it should be evaluated promptly and accu-
rately. It is particularly important to differentiate between
gallstone-induced acute pancreatitis, which requires treat-
ment of the biliary system, and alcohol-induced acute pan-
creatitis, which requires a different form of treatment.
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Abstract
The currently used diagnostic criteria for acute pancreatitis in
Japan are presentation with at least two of the following three
manifestations: (1) acute abdominal pain and tenderness in
the upper abdomen; (2) elevated levels of pancreatic enzyme
in the blood, urine, or ascitic ﬂuid; and (3) abnormal imaging
ﬁndings in the pancreas associated with acute pancreatitis.
When a diagnosis is made on this basis, other pancreatic dis-
eases and acute abdomen can be ruled out. The purpose of
this article is to review the conventional criteria and, in par-
ticular, the various methods of diagnosis based on pancreatic
enzyme values, with the aim of improving the quality of diag-
nosis of acute pancreatitis and formulating common interna-
tionally agreed criteria. The review considers the following
recommendations:
— Better even than the total blood amylase level, the blood
lipase level is the best pancreatic enzyme for the diagnosis
of acute pancreatitis and its differentiation from other
diseases.
—A   pivotal factor in the diagnosis of acute pancreatitis is
identifying an increase in pancreatic enzymes in the blood.26 M. Koizumi et al.: Diagnostic criteria for acute pancreatitis
Clinical questions
CQ1. Are clinical symptoms and signs useful in diag-
nosing acute pancreatitis?
CQ2. Which pancreatic enzymes should be mea-
sured to diagnose acute pancreatitis?
CQ3. What is the optimal examination for
diagnosing acute pancreatitis?
CQ4. Is US effective in diagnosing acute
pancreatitis?
CQ5. Is MRI effective in diagnosing acute
pancreatitis?
CQ6. Is CT effective in diagnosing acute
pancreatitis?
CQ7. Are plain X-ray examinations useful in
diagnosing acute pancreatitis?
CQ8. Is the etiology of a speciﬁc case of acute
pancreatitis necessary for its diagnosis?
Introduction
The diagnosis of acute pancreatitis has been based on
the clinical manifestations and results of blood-
biochemistry tests, but there are few common criteria
that strictly specify the parameters to be used in
diagnosis.
The criteria currently used to diagnose acute pancre-
atitis in Japan were originally developed by the Re-
search Group for Intractable Diseases and Refractory
Pancreatic Diseases, which was sponsored by the
Japanese Ministry of Health and Welfare (now the
Japanese Ministry of Health, Labour, and Welfare).
The Research Group states that acute pancreatitis
should be diagnosed if the patient presents with at least
two of the following three criteria: (1) acute abdominal
pain and tenderness in the upper abdomen; (2) elevated
levels of pancreatic enzymes in blood, urine, or ascitic
ﬂuid; and (3) the presence of abnormal imaging ﬁndings
in the pancreas that are associated with acute pancreati-
tis. When a diagnosis is made on this basis, other pan-
creatic diseases and acute abdomen can be ruled out.
In Japan, many surgeons and physicians specializing
in digestive system diseases and emergency medicine
are familiar with abdominal ultrasonography (US) and
perform it routinely. Magnetic resonance imaging
(MRI) is less popular than X-rays or computed tomo-
graphy (CT) scanning and is not a routine procedure in
emergency examinations for abdominal diseases.
The purpose of this article is to review the conven-
tional criteria and, in particular, the various methods of
diagnosis based on pancreatic enzyme values, with the
aim of improving the quality of the diagnosis of acute
pancreatitis and of formulating common, internation-
ally agreed upon criteria.
Diagnostic criteria
Clinical symptoms and signs
Clinical question (CQ) 1. Are clinical symptoms and
signs useful in diagnosing acute pancreatitis?
It is essential to interview all patients (including those
with consciousness disorders or who are in a state of
shock), take their medical histories, and perform a
physical examination (Recommendation A)
Abdominal pain, pain radiating to the back, anorexia,
fever, nausea and vomiting, and decreased bowel sounds
are frequent manifestations of acute pancreatitis (Tables
1 and 2) (Level 4).1,2 However, these features are not
speciﬁc to acute pancreatitis, and when a patient pre-
sents with these manifestations, acute pancreatitis must
be differentiated from other acute abdominal diseases.
Acute pancreatitis accounts for 2% to 3% of all acute
abdominal diseases (Level 2b, unknown)3,4 and in a very
few patients there is no abdominal pain (Level 2b).5
Table 1. Symptoms and signs of acute pancreatitis
Symptoms and signsa (%) Symptoms and signsb (%)
Abdominal pain 90 Abdominal pain 95
Abdominal muscular rigidity 80 Pain radiating to the back 50
Fever 80 Anorexia 85
Nausea, vomiting 70 Nausea, vomiting 75
Metorism 60 Decreased bowel sounds 60
Ileus, subileus 55 Fever 60
Jaundice 30 Abdominal guarding 50
Shock 20 Shock 15
Neurological symptoms 10 Jaundice 15
Hematoemesis 10
aAdapted from Malfertheiner P. and Kemmer T.P.1
bAdapted from Corsetti and Arvan2M. Koizumi et al.: Diagnostic criteria for acute pancreatitis 27
tis are 85% to 100% and 84.7% to 99.0% (Level 2a),8
respectively. The blood lipase value is more sensitive
than blood amylase (Levels 2b-4)11–13 and provides diag-
nostic capability similar to that of blood P-amylase
(Level 2b).13 Blood lipase is considered a valuable diag-
nostic tool, because abnormally high values persist for
longer than abnormal blood amylase levels (Level 2b),14
and it is more sensitive in terms of detecting the pres-
ence of acute alcohol-induced pancreatitis. The com-
bined use of blood amylase and blood lipase levels
(Level 2a)8  does not facilitate the diagnosis of acute
pancreatitis.
The above ﬁndings lead to the conclusion that the
blood lipase level is an important indicator in the diag-
nosis of acute pancreatitis and that the measurement of
the blood lipase level should be given top priority. Mea-
surement of the lipase level is of primary importance
when the blood amylase level of a patient suspected of
having acute pancreatitis is normal.
Blood amylase (blood total amylase)
CQ3. What is the optimal examination for diagnos-
ing acute pancreatitis?
Identifying an increase in the level of pancreatic en-
zymes in the blood is a pivotal factor in the diagnosis
of acute pancreatitis (Recommendation A)
When the cutoff blood amylase level is set at the upper
limit of normal, it has a sensitivity of 91.7% to 100% and
a speciﬁcity of 71.6% to 97.6% for the diagnosis of acute
pancreatitis. If the cutoff level is set higher, speciﬁcity
Table 2. Symptoms and signs at onset of acute pancreatitisa
Symptoms and signs No. of cases (%)
Upper abdominal pain 1150 95%
Nausea–vomiting 436 36%
Pain radiating to the back 262 22%
Anorexia 93 8%
Meteorism 85 7%
Diarrhea–soft stool 44 4%
Fever–chill 12 1%
Loss of consciousness 9 1%
General fatigue 7 1%
aPresented by the Intractable Pancreatic Disease Investigation and
Research Group of the Japanese Ministry of Health and Welfare
(JMHW) in 2000
Table 3. Comparison of diagnostic tests for acute pancreatitis
Total amylase Lipase Pancreatic amylase
Sensitivity Very good (95%–100%) Very good (90%–100%) Good (84%–100%)
Speciﬁcity Low; (70%); inﬂuenced Very good (99%); at upper Good (40%–97%); inﬂuenced by
by cutoff level limit of normal cutoff level
Positive predictive value (PPV) Very low (15%–72%) Very good (90%) 50%–96%
Negative predictive value (NPV) 97%–100% 95%–100% 70%–100%
Reliability Good Good Poor
Adapted from Agarwal et al.9
Acute pancreatitis is sometimes manifested by
discoloration of the skin, such as Grey Turner’s sign (on
the lateral abdominal wall), Cullen’s sign (around the
navel), and Fox’s sign (over the lower portion of the
inguinal ligament). However, because these signs ap-
pear in only 3% (Level 2b)6 of patients, and because
they are also observed in patients with other diseases
(Level 4)7 and are often seen 48 to 72h after the onset of
pancreatitis, their diagnostic signiﬁcance is low.
Blood and urine tests
Blood lipase
CQ2. Which pancreatic enzymes should be mea-
sured to diagnose acute pancreatitis?
When making a diagnosis of acute pancreatitis or a
differential diagnosis from other diseases, the blood
lipase level is the best pancreatic enzyme parameter,
even better than the total blood amylase level (Recom-
mendation A)
Comparisons of measurements of various pancreatic
enzymes to detect the presence of acute pancreatitis
(Level 2a)8 have shown that the blood lipase level is
almost as sensitive as the total blood amylase level and
has better speciﬁcity (Tables 3 and 4).9,10
According to Apple et al.,8 the sensitivity and speci-
ﬁcity of blood lipase in the diagnosis of acute pancreati-
Table 4. Sensitivity and speciﬁcity of amylase and other pan-
creatic enzymes
Sensitivity (%) Speciﬁcity (%)
Total amylase 67–100 85–98
Pancreatic amylase 67–100 83–98
Lipase 82–100 82–100
Trypsin 89–100 79–83
Elastase-1 97–100 79–96
Adapted from Thomson et al.1028 M. Koizumi et al.: Diagnostic criteria for acute pancreatitis
improves, but sensitivity declines. When the cutoff level
is set at 1000IU/l, speciﬁcity improves to 100%, but
sensitivity declines to 60.9% (Levels 2a-4; Table 5).9,11,16–
19  Sensitivity declines because (1) the blood amylase
level does not rise as much in many patients with
chronic alcoholic pancreatitis with acute exacerbations
as it does in patients with acute pancreatitis (Level
2b)12,20 and (2) since the elevated blood amylase level
declines almost immediately and is maintained for a
shorter time than are other elevated pancreatic enzyme
levels, the level must be measured soon after the onset
(Levels 3b-4).21,22 The blood amylase level seldom rises
in acute pancreatitis caused by hyperlipidemia (Level
3b).23 Because many other diseases besides pancreatitis
are associated with hyperamylasemia (Table 6; Level
2a),8 it is necessary to measure extrapancreatic enzymes
with high speciﬁcity for pancreatitis in order to make a
proper differential diagnosis of pancreatitis. If the blood
Table 5. Sensitivity, speciﬁcity, PPV, and NPV for serum amylase, P-isoamylase, and lipase assays
Cutoff
Upper normal value
Author Year Methodology limit (IU/l) (IU/l) Sensitivity Speciﬁcity PPV NPV
Amylase Pace16 1985 Phadebas 300 300 100.0 71.6 15.6 100
Steinberg17 1985 Phadebas 326 326 94.9 86.0 75.5 97.4
600 92.3 100.0 100.0 96.6
Ventrucci18 1986 Phadebas 377 377 91.7 77.8 35.5 98.6
Thomson10 1987 Phadebas 316 316 95.6 97.6 91.7 98.8
1000 60.9 100.0 100.0 90.4
P-amylase Koehler19 1982 Cellulose 52 52 84.2 38.8 59.3 70.0
electrophoresis
Steinberg17 1985 Wheat protein 181 181 92.3 85.1 73.5 96.1
inhibitor 375 84.0 96.5 91.7 93.3
Pace16 1985 Cellulose 120 225 100.0 48.9 17.9 100.0
electrophoresis
Ventrucci18 1986 Phadebas 220 220 100.0 84.4 46.2 100.0
Lipase Steinberg17 1985 Turbidimetric 72 75 86.5 99.0 97.0 95.1
Ventrucci18 1986 ELISA 62 62 91.7 84.7 42.3 98.9
Thomson10 1987 Seragen-lipase 68 68 100.0 96.0 85.0 100.0
PPV, positive predictive value; NPV, negative predictive value
Adapted from Agarwal et al.9
Table 6. Conditions associated with elevation of serum amylase
Pancreatic diseases Extrapancreatic neoplasms
Pancreatitis Solid tumors of ovary, prostate, lung, esophagus, breast, thymus
Complications of pancreatitis (pseudocyst, abscess) Multiple myeloma
Trauma (including surgery and ERCP) Pheochromocytoma
Ductal obstruction Miscellaneous
Pancreatic carcinoma Renal failure
Cystic ﬁbrosis (early) Renal transplant
Salivary diseases Macroamylase
Infection (mumps) Burns
Trauma (including surgery) Acidosis (ketotic and nonketotic)
Radiation Pregnancy
Ductal obstruction Cerebral trauma
Gastrointestinal diseases Drug-induced (morphine, diuretics, corticosteroids)
Perforated/penetrating peptic ulcer Abdominal aortic aneurysma
Perforated/obstructed bowel Postoperative (unrelated to trauma)
Mesenteric infarction Anorexia, bulimia nervosa
Appendicitis Idiopathic elevation
Liver disease (hepatitis, cirrhosis)
Gynecologic diseases
Ruptured ectopic pregnancy
Ovarian or fallopian cysts
Pelvic inﬂammatory disease
Adapted from Apple et al.8M. Koizumi et al.: Diagnostic criteria for acute pancreatitis 29
enzyme value and/or imaging ﬁndings do not allow for a
diagnosis of acute pancreatitis in a patient with ascites,
the amylase level in the ascitic ﬂuid may be useful in
making the diagnosis. However, it is not usually very
useful, because the amylase level in the ascitic ﬂuid
sometimes increases in other diseases, including alimen-
tary tract perforation.
P-amylase (amylase isozyme)
The blood P-amylase level is considered useful in the
differential diagnosis of hyperamylasemia, and, while
one report claimed it could identify 83% of patients (19/
23) with hyperamylasemia independent of pancreatic
disease (Level 4),24 others suggest a capability of only
20% to 44% (Levels 3b-4).16,19 There is a report describ-
ing the blood P-amylase level as a useful indicator, be-
cause the abnormally high level is maintained for longer
than are the abnormal blood amylase levels in acute
pancreatitis (Levels 3b),25 but another report showed
that the blood P-amylase level did not improve sensitiv-
ity or speciﬁcity (Level 2b).17 The diagnostic value of the
P-amylase level for acute pancreatitis requires further
study.
Blood elastase-1 and other pancreatic enzymes
Clinically measurable extrapancreatic enzymes can be
roughly classiﬁed into blood and urine amylase, P-
amylase (amylase isozyme), and serum lipase, whose
enzymatic activity is measured by an enzyme-chemical
method; and serum elastase-1, serum trypsin, and serum
phospholipase A2 (PLA2), whose antigen levels are
measured immunologically. Because the immunological
measurements require a lot of time, it is difﬁcult to use
them as a routine procedure for the diagnosis of acute
pancreatitis. A latex agglutination method has enabled
the rapid, convenient measurement of the serum
elastase-1 level. Elastase-1 has the advantage of main-
taining an abnormally high value for longer than the
levels of other pancreatic enzymes (Level 3b),26,27  al-
though the ability to diagnose or assess the severity of
acute pancreatitis (Level 2b)28 was not improved by the
combined use of the serum elastase-1 and blood amy-
lase levels.
Trypsin is a key enzyme present at the onset of acute
pancreatitis, but its activity cannot be measured, be-
cause it is too rapidly inactivated by protease inhibitors
in the blood, and therefore the quantity of the antigen
should be measured immunologically. Blood trypsin has
high sensitivity for the diagnosis of acute pancreatitis
(Level 2b).23,29 The blood PLA2 level rises markedly in
acute pancreatitis and is correlated with the severity
(Levels 3b-4).30,31 Qualitative evaluation of urine trypsi-
nogen-2 with test paper to determine its rate of positiv-
ity in acute pancreatitis has shown that it has a diagnos-
tic ability similar to that of lipase, and it is expected to
be useful in early diagnosis (Levels 3b-4).32,33
Imaging examinations
Ultrasonography (US)
CQ4. Is US effective in diagnosing acute
pancreatitis?
Ultrasonography (US) is one of the diagnostic
procedures that should be performed ﬁrst in all
patients suspected of having acute pancreatitis (Rec-
ommendation A)
Ultrasonography (US) is capable of identifying pancre-
atic enlargement and inﬂammatory changes near the
pancreas, and it may be useful in diagnosing acute pan-
creatitis. Although, in severe cases, visualization of the
pancreas and peripancreatic tissue may be impaired by
gas in the intestinal tract (Levels 1b-2b),34,35 the visual-
ization rate is 62% to 90% for the pancreas, 100% for
the peripancreatic tissue in the anterior paranephric
cavity, 90% in the cavity of the lesser omentum, and
65% in the mesentery (Levels 1b-2b).34,35 Ultrasonogra-
phy may also visualize abnormal ﬁndings associated
with the etiology and morbidity of acute pancreatitis,
such as ascites, gallstones, and cholangiectasis. It is
particularly important to check for the presence of
cholecholithiasis and cholangiectasis when judging
whether endoscopic sphincterotomy for gallstone pan-
creatitis is required. It is desirable to examine patients
repeatedly, using US, even when no gallstones are de-
tected by the initial examination. US is also useful for
screening for comorbidities such as aneurysms.
Magnetic resonance imaging (MRI)
CQ5. Is MRI effective in diagnosing acute
pancreatitis?
MRI is one of the most important imaging procedures
for the diagnosis of acute pancreatitis and its
intraabdominal complications (Recommendation B)
MRI scanning visualizes pancreatic enlargement and
the inﬂammatory changes around the pancreas (Level
2c)37 and can distinguish the intestinal tract from the
necrotic part of the pancreas. Gadolinium-DTPA (Gd-
DTPA)-enhanced MRI can visualize foci of pancreatic
necrosis (Level 2b).38 MRI accurately depicts the state
of necrosis, the main pancreatic ducts, and the extent of
inﬂammation, and it has more value than CT (Levels
2b-3c).39,40 MRI scanning has the advantage of no X-ray30 M. Koizumi et al.: Diagnostic criteria for acute pancreatitis
exposure. However, because MRI takes much longer
than CT scanning and requires the removal of all metal
objects (such as respirators and transfusion pumps) be-
fore the examination, it is not routinely used to diagnose
acute pancreatitis in Japan, where the system for MRI
use is not yet adequate. However, magnetic resonance
cholangiopancreatography (MRCP) is often required to
identify the etiology of acute pancreatitis, such as
cholecholithiasis (Level 4)41 and abnormal pancreatico-
choledochal junction (abnormal junction of the
pancreatobiliary ducts; Level 4).42 MRI scanning can be
performed earlier than CT, because it requires no
operation of the duodenal papilla and there is no risk
of aggravating acute pancreatitis. Although MRCP is
noninvasive, it has the disadvantages of less clear imag-
ing than endoscopic retrograde cholangiopancreato-
graphy (ERCP) and impaired visualization due to
peripancreatic ﬂuid collection.
Computed tomography (CT)
CQ6. Is CT effective in diagnosing acute
pancreatitis?
CT is one of the most important imaging procedures
for the diagnosis of acute pancreatitis and its intraab-
dominal complications. CT should be performed when
the diagnosis of acute pancreatitis cannot be estab-
lished on the basis of the clinical ﬁndings and the
results of blood and urine tests and US, or when the
etiology of the pancreatitis is unknown (Recommenda-
tion B)
CT is unaffected by the adipose tissue in the abdominal
wall and inside the abdominal cavity, and it provides
clear local images (Level 1b).34 CT ﬁndings useful for
the diagnosis of acute pancreatitis include an enlarged
pancreas, inﬂammatory change around the pancreas,
ﬂuid collections, uneven density of the pancreatic pa-
renchyma, and traumatic disruption of the pancreas
(Figs. 1, 2, and 3). Gas patterns visualized inside and
around the pancreas are often due to ﬁstula formation
with the intestinal tract and infection by gas-forming
anaerobes (Level 1c).36
CT scanning allows for the differentiation of
acute pancreatitis from other intraabdominal diseases,
such as perforation caused by a gastroduodenal ulcer,
and it allows the diagnosis of comorbidities in intra-
abdominal organs and complications of pancreatitis; it is
also an important procedure for assessing the severity of
Fig. 1. Plain computed tomography (CT) shows enlargement
of the pancreatic body and tail and poorly deﬁned margins of
the pancreatic body
Fig. 2. Plain CT shows enlarged pancreas, associated hazi-
ness, and increased density of peripancreatic fat
Fig. 3. Contrast-enhanced CT shows low-density region of the
pancreatic tail and ﬂuid in the left anterior pararenal spaceM. Koizumi et al.: Diagnostic criteria for acute pancreatitis 31
acute pancreatitis and selecting a treatment plan. CT
scanning is especially needed in severe acute pancreati-
tis, where adequate information cannot be obtained by
US because of abdominal pain and the complication of
ileus.
Plain X-rays
CQ7. Are plain X-ray examinations useful in diag-
nosing acute pancreatitis?
When acute pancreatitis is suspected, chest and ab-
dominal X-ray examinations should be performed to
check for the presence of any abnormal ﬁndings caused
by acute pancreatitis (Recommendation A)
Abdominal X-ray examinations in acute pancreatitis
visualize ileus, localized sentinel loop signs in the left
upper abdomen, enlarged duodenal loops and gas
collections, colon cutoff signs in the right colon, retro-
peritoneal gas collection, calciﬁed gallstones, and
pancreatolithiasis.
Chest X-rays visualize pleural effusion, acute respira-
tory distress syndrome (ARDS), and pneumonia. None
of these ﬁndings, however, are speciﬁc enough to make
a diagnosis of acute pancreatitis (level 4).44 X-ray exami-
nations are necessary, however, to evaluate the clinical
course of acute pancreatitis and to differentiate acute
pancreatitis from other diseases, such as alimentary
tract perforation.
Search for the etiology
CQ8. Is the etiology of a speciﬁc case of acute pan-
creatitis necessary for its diagnosis?
The etiology of acute pancreatitis may have a crucial
impact on treatment policy as well as the severity as-
sessment, and it should be determined promptly and
accurately. It is particularly important to differentiate
acute gallstone pancreatitis, which requires treatment
of the biliary system, from acute alcoholic pancrea-
titis, which requires a different form of treatment
(Recommendation A)
Abdominal US should be performed immediately with
the start of treatment in order to detect the presence of
abnormal ﬁndings associated with the etiology of acute
pancreatitis, such as gallstones or dilated bile ducts.
If acute gallstone pancreatitis is accompanied by
jaundice, liver disorders, or cholangiectasis, and where
cholecholithiasis is suspected, ERCP is required imme-
diately after the onset, but it should be performed only
for the purpose of endoscopic treatment, sphinctero-
tomy, and biliary drainage.
ERCP should be performed in patients with acute
gallstone pancreatitis who are strongly suspected of
having gallstones, but only for the purposes of deter-
mining etiology and performing endoscopic treatment.
ERCP has several risk factors (level 2b).44  Because
ERCP may exacerbate the inﬂammation at the onset of
acute pancreatitis, it should be performed only for lim-
ited indications. The guidelines of the British Society
of Gastroenterology recommend the performance of
ERCP in patients with jaundice, liver disorders, or
cholangioectasis, and in those who are strongly sus-
pected of having cholecholithiasis and have had re-
peated attacks of pancreatitis.45 Patients with repeated
attacks of pancreatitis may have anatomical disorders,
such as malfusion of the biliary ducts or abnormal junc-
tion of the pancreatobiliary ducts, or they may have a
tumor or choledocholithiasis. Because such features are
difﬁcult to visualize using other procedures, it is recom-
mended that ERCP be performed as a standby proce-
dure to differentiate the etiology of these disorders and
complications.45
There is a report claiming that endoscopic US (EUS)
can identify cholecholithiasis in 77.8% of patients
whose etiology has not been identiﬁed by blood tests,
US, and CT scanning (level 2b).46 EUS is indicated in
any patient with severe acute pancreatitis in whom
choledocholithiasis is strongly suspected, but it should
be performed only after adequate evaluation of the
patient’s general condition. ERCP should be performed
without delay. Cases in which cholecholithiasis cannot
be diagnosed by extracorporeal US are a good indica-
tion for EUS, after the attack subsides.
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